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ABSTRACT
Introduction: Breast cancer affects the lives of millions of women each year in
the United States. Early detection by mammography screening can reduce the risk for
advanced stages of breast cancer and improve the probability of long-term survival in
women. Electronic medical records (EMRs) have been identified as a successful
approach for increasing the offering of preventive care in breast cancer. This study
examines the impact of EMR usage, and EMR generated provider reminders on physician
ordering or providing of mammography screenings.
Methods: This study used survey data from the 2008-2010 National Ambulatory
Medical Care Survey (NAMCS). Our sample included non-federal office-based
physicians (n=2,785), and women age 45 and older who visited a physician from 20082010 (n=8,348). Chi-square analysis, ICD-9 coding and logistic regression analysis were
performed to analyze the weighted data.
Results: Physician EMR use was not significantly associated with the odds that a
woman would have a mammogram provided/ordered. However, significant findings of
the study indicate that women on Medicare/Medicaid/SCHIP (OR=0.633, 95% CI 0.2710.919) have significantly lower odds of receiving mammography screenings compared to
women who have private insurance. In addition, women who visit obstetrics/gynecology
(OR = 0.190, 95% CI 0.142-0.254) and internal medicine practices (OR = 0.553, 95% CI
0.393-0.778) have significantly lower odds of receiving a mammography, compared to
women visiting general/family practices.
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Conclusions: Women age 45 and older who have private are more likely to have a
mammogram ordered or provided by a physician, compared to those women who are
poor or without insurance. Based on our findings, women are having more general/family
physicians providing them with routine care, and that these physicians are experiencing
difficulty referring Medicare/Medicaid/SCHIP patients for specialty care. This may be
due to patients being reluctant to pay a co-pay for mammography screenings, the short
supply of specialists in the area, long waiting lists for specialists, specialists not accepting
or limiting the number of patients who are covered by Medicare/Medicaid/SCHIP or selfpay, and low reimbursement rates. Further research is needed to uncover the true reasons
as to why physicians are ordering/providing mammography screenings for women who
are poor or on Medicare/Medicaid/SCHIP at lower rate than women who have private
insurance.
In 2014, the Affordable Care Act is set to expand preventive services under the
Medicaid program to cover recommended preventive services and immunizations. The
referral process will be less difficult for physicians who refer self-pay and
Medicare/Medicaid/SCHIP patients to specialists because patients will no longer have a
co-pay for mammography screenings. In addition, we acknowledge that the HITECH
statue authorizes incentive payments through Medicare and Medicaid to physicians and
hospitals that use EMRs privately and securely to achieve specified improvements in care
delivery. The incentive payments will help encourage physicians in all specialties to
improve the ordering/providing of mammography screenings to women who are on
Medicare/Medicaid/SCHIP in all races, ethnicities, and socioeconomic backgrounds.
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CHAPTER 1
INTRODUCTION
Cancer is a major public health problem that financially burdens people diagnosed
with cancer, their families, and society as a whole. In 2007, the National Institutes of
Health estimated the overall annual costs for cancer in the United States at $226.8 billion.
The direct medical costs for cancer, which are the total of all health expenditures, were
estimated at $103.8 billion in 2007. Moreover, the indirect mortality costs, which are the
costs of productivity due to premature death, were estimated at 123.0 billion in 2007
(American Cancer Society, 2012).
According to the American Cancer Society one of the major costs of cancer is
cancer treatment. A lack of health insurance and other barriers to health care prevent
many Americans from getting appropriate health care (American Cancer Society, 2012).
The United States Census Bureau estimated about 51 million people were uninsured in
2009. In fact, about 28% of Americans ages 18 to 34 had no health insurance for at least
part of 2009, and 10% of children in the United States had no health insurance coverage
in 2009 (American Cancer Society, 2012).
The American Cancer Society acknowledges that uninsured patients and those
from ethnic minorities are substantially more likely to be diagnosed with cancer at a later
stage, where treatment can be more extensive and more costly. In fact, this leads not only
to higher medical costs, but also poorer outcomes and higher cancer death rates
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(American Cancer Society, 2012). Cancer is the cause of 1 in 4 deaths in the United
States each year (Jemal et al., 2009). In women, one of the most commonly diagnosed
forms of cancer is breast cancer. Breast cancer ranks first as the most common cause of
cancer deaths among women in the United States (American Cancer Society, 2012). In
2011, there were 39,000 deaths from breast cancer, 240,000 new cases of invasive breast
cancer, and 57,650 new cases of non-invasive breast cancer (Surveillance Epidemiology
and End Results, 2012). In 2012, breast cancer is expected to account for 29% of all new
cancer cases among women (Siegel, Naishadham and Jemal, 2012).
Breast cancer is a malignant tumor that starts in the cells of the breast and can
spread throughout the body in stages (American Cancer Society, 2012). Stage 0 is used to
describe non-invasive breast cancers. In stage 0, there is no evidence of cancer cells or
non-cancerous abnormal cells spreading to outside areas of the breast (Mankoff, 2012).
Stage I is used to describe invasive breast cancer cells that have invaded the
normal surrounding tissue of the breast. Stage I is divided into subcategories known as IA
and IB. In stage IA, cancerous tumors that measure up to 2 centimeters are found in the
breast. However, cancer has not spread outside the breast or to the lymph nodes (Mankoff,
2012).
In stage IB, small groups of cancer cells are found in the axillary lymph nodes.
These cancer cells may be between 0.2 millimeters and 2 millimeters in size. A tumor
may also be found in the breast that is 2 centimeters in size or less, and small groups of
cancer cells between 0.2 millimeters and 2 millimeters may be found in the lymph nodes
in stage IB (Mankoff, 2012).
Stage II is divided into subcategories, known as IIA and IIB. Stage IIA invasive
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breast cancer can exist in any of the following three ways. The first way that stage IIA
invasive breast cancer can exist is if cancer cells are found in the lymph nodes under the
arm. However, tumors do not have to be present in the breast. The second way that stage
IIA invasive breast cancer can exist is if a tumor measuring up to 2 centimeters in size is
found in the breast and cancer has spread to the axillary lymph nodes (Mankoff, 2012).
Lastly, stage IIA invasive breast cancer can exist if a tumor measuring between 2
centimeters and 5 centimeters in size is found in the breast, and cancer has not spread to
the axillary lymph nodes.
For breast cancer to be diagnosed as stage IIB, a tumor measuring between 2
centimeters and 5 centimeters in size must be present in the breast, and the cancer must
have spread to the axillary lymph nodes. Stage IIB can also exist if a tumor measuring 5
centimeters in size or larger is found in the breast and cancer has not spread to the
axillary lymph nodes (Mankoff, 2012).
Stage III is divided into subcategories known as IIIA, IIIB, and IIIC. Stage IIIA
invasive breast cancer exists when: (1) tumors are not found in the breast, cancer is found
in axillary lymph nodes, or cancer has spread to lymph nodes near the breastbone; (2) the
cancer is any size and it has spread to axillary lymph nodes (Mankoff, 2012). Similarly,
stage IIIB can exist in any of the following ways: (1) cancer may be any size and has
spread to the chest wall and/or skin of the breast. Cancer may also have spread to axillary
lymph nodes; (2) the cancer has only spread to lymph nodes near the breastbone.
For breast cancer to be diagnosed as stage IIIC, there must be no signs of breast
tumors. However, if there is a tumor present, it can be any size. The cancer in this stage
may spread to the chest wall and/or the skin of the breast, to lymph nodes above or below
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the collarbone, and to the axillary lymph nodes or lymph nodes near the breastbone
(Mankoff, 2012). Lastly, stage IV is an advanced stage of invasive cancer. In this stage,
cancer has spread beyond the breast to nearby lymph nodes and other organs of the body,
such as the lungs, distant lymph nodes, skin, bones, liver, or brain
Early detection by screening and treatment can decrease the risk for advanced
stages of breast cancer and improve the probability of long-term survival in women.
Screening is defined as the identification of individuals among an asymptomatic
population who have a specified disease at a time when intervention may result in
improvement of prognosis of the disease (Islam and Aziz, 2012). Studies have shown that
screening for breast cancer has reduced incidence and mortality since 1996 at a rate of 2%
per year (Edwards et al, 2010).
There are three types of breast cancer screenings, a clinical breast exam,
mammogram, and breast self-examinations. A clinical breast exam is an exam where the
doctor checks the breasts using a finger-touch technique. A mammogram is a low dose xray exam of the breasts used to observe changes in breast tissue that cannot be felt during
a clinical breast exam (Womenshealth.gov, 2012). Due to the fact that neither clinical
breast exams nor mammography is 100% sensitive, breast self-exams have been advised
as an important screening method among women older than 20 years of age (Humphrey,
Helfand, Chan, and Woolf, 2002).
The American Cancer Society acknowledges the importance of annual breast
cancer screenings by recommending that women in their 20’s perform breast selfexaminations monthly and report any changes to their doctors. Women who choose to do
breast self-examinations should have their breast self-examination technique reviewed
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during their physical exam by a health professional. The American Cancer Society
acknowledges that by doing the exam regularly, women get to know how their breasts
normally look and feel and can more readily detect any signs or symptoms if a change
occurs, such as development of a lump or swelling, skin irritation or dimpling, nipple
pain or retraction, redness or scaliness of the nipple or breast skin, or a discharge other
than breast milk (American Cancer Society, 2012).
Breast self-examinations are widely recommended for breast cancer prevention
and play a small role in finding breast cancer compared with finding a breast lump by
chance or simply being aware of what is normal for each woman. The American Cancer
Society believes that some women feel very comfortable performing breast selfexaminations regularly, which involves a systematic step-by-step approach to examining
the look and feel of their breasts (American Cancer Society, 2012). Other women are
more comfortable simply looking and feeling their breasts in a less systematic approach,
such as while showering or getting dressed or doing an occasional thorough exam.
Sometimes, women are so concerned about performing breast self-examinations correctly
that they become stressed over the technique. Performing breast self-examinations
regularly is one way for women to know how their breasts normally look and feel and to
notice any changes (American Cancer Society, 2012).
Studies have shown that breast self-examinations increase the number of breast
biopsies performed because of false-positives (Hackshaw and Paul, 2003; Elmore,
Armstrong, Lehman, and Fletcher, 2005). For this reason, it is also recommended for
women in their 20’s and 30’s to receive a clinical breast exam every 3 years and women
40 and over receive a clinical breast exam and mammogram annually (American Cancer
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Society, 2012). Studies have shown that clinical breast examinations detect some cancers
that are missed by mammography (Elmore, Armstrong, Lehman, and Fletcher, 2005).
Women who are 40 and over are recommended to schedule their annual clinical breast
exam shortly before their annual mammogram so that any suspicious areas found during
their clinical breast exam can be reviewed in the mammogram (American Cancer Society,
2012).
The American Cancer Society recommends that women at high risk, greater than
20% lifetime risk, should get an MRI and a mammogram every year. An MRI should be
used in addition to a mammogram, and not instead of a mammogram screening. An MRI
is a more sensitive test that is more likely to detect cancer than a mammogram. However,
it may still miss some cancers that a mammogram would detect. Women who are at high
risk include those who have a known BRCA1 or BRCA2 gene mutation; have a firstdegree relative (parent, brother, sister, or child) with a BRCA1 or BRCA2 gene mutation
but have not had genetic testing themselves; have a lifetime risk of breast cancer of 20%
to 25% or greater, according to risk assessment tools that are based mainly on family
history; have had radiation therapy to the chest when they were between the ages of 10
and 30 years; have Li-Fraumeni syndrome, Cowden syndrome, Bannayan-RileyRuvalcaba syndrome, or have first-degree relatives with one of these syndromes
(American Cancer Society, 2012).
Women at moderately increased risk, 15% to 20% lifetime risk, should speak with
their doctors about the benefits and limitations of adding MRI screening to their yearly
mammogram. Women at moderately increased risk include those who have a lifetime risk
of breast cancer of 15% to 20%, according to risk assessment tools that are based mainly
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on family history; have extremely dense breasts or unevenly dense breasts when viewed
by mammograms; or have a personal history of breast cancer, ductal carcinoma in situ
(DCIS), lobular carcinoma in situ (LCIS), atypical ductal hyperplasia (ADH), or atypical
lobular hyperplasia (ALH) (American Cancer Society, 2012).
Yearly MRI screening is not recommended for women whose lifetime risk of
breast cancer is less than 15%. Screening with MRI and mammograms should begin at
age 30 years for women at high risk and continue for as long as a woman is in good
health (American Cancer Society, 2012). The American Cancer Society acknowledges
that the evidence is limited regarding the best age at which to start screening. This
decision should be based on shared decision-making between patients and their health
care providers, taking into account personal circumstances and preferences.
It has been the primary objective of Healthy People 2010 to increase breast cancer
screening procedures for ethnic and racial minority groups. Research has found that
Caucasian women age 40 to 74 years reported having lower breast cancer preventive care
(mammography and clinical breast exams) than African American, Cuban, and Puerto
Rican women. Within the past year, Caucasian women reported using mammograms and
clinical breast exams 59.8% and 66.0%, respectively. In comparison, the following
racial/ethnic groups reported using mammograms and clinical breast exams at a higher
rate: African American (60.6%), Cuban (65.1%), and Puerto Rican (62.5%) women.
Women of Mexican origin lag far behind all of these racial and ethnic groups in breast
cancer screening rates with only 47.8% using mammograms and 54.5% performing
clinical breast exams (Miranda, Tarraf, & Gonzalez, 2011).
Studies have shown that racial and ethnic disparities exist in breast cancer. In a
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study conducted in 2005, evidence revealed a lower incidence of breast cancer among
African American women than Caucasian women, corresponding to 29 cases and 44
cases per 10, 000 person years for African American and Caucasian women, respectively
(Chlebowski, Chen, Anderson, Rohan, Aragaki, Lane, Dolan, Paskett, McTiernan,
Hubbell, Adams-Campbell, and Prentice, 2005). However, among women who developed
breast cancer, African Americans had higher mortality than white women, corresponding
to 9 and 6 deaths per 10,000 person-years from diagnosis in African American and white
women, respectively.
Several factors have been suggested that contribute to higher breast cancer
mortality in African American women than in Caucasian women. The factors include
poorer socioeconomic status with reduced access to health care, a lower frequency of
mammography with delayed diagnosis, and reduced chemotherapy dosage related to
underlying neutropenia (Newman, Mason, Cote, Vin, Carolin, Bouwman et al., 2002;
Henson, Chu, Levine, 2003; Li, Malone, Daling, 2003; O’Malley, Le, Glaser, Shema,
West, 2003). However, a disparity in survival between Caucasian and African American
women with breast cancer treated in the same health care systems, as well as in the same
cancer clinical trial group suggests that factors other than access to health care or
mammography/treatment differences play a role in this process. These factors include
differences in obesity and high-grade cancers, which among African American women
was twice that of Caucasian women (Jatoi, Becher, Leake, 2003; Albain, Unger, Hutchins
et al., 2003).
For these reasons, it is important for women of all racial and ethnic backgrounds
to receive mammography screenings. To improve the offering of mammography
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screening, the use of electronic medical records (EMRs) with provider reminders may be
helpful. Research has shown that provider reminders may be a successful approach for
increasing the offering and delivery of preventive care for diseases such as breast cancer
(Dexheimer et al., 2008).
EMRs with provider reminders allow physician practices to improve clinical
efficiency and pursue more powerful quality improvement programs than is possible with
paper-based records (Miller and Sim, 2004). It is necessary for health care providers to
recognize the importance of provider reminders and use them to offer patients preventive
care for breast cancer. This dissertation contributes to the literature by investigating the
impact of provider reminders on provider offerings of mammography screening using the
2008-2010 National Ambulatory Medical Care Surveys.
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CHAPTER 2
LITERATURE REVIEW
2.1 BREAST CANCER INCIDENCES AND MORTALITY
Breast cancer is one of the 3 most commonly diagnosed types of cancer among
women in 2012 (Yasmeen, Romano, Tancredi, Saito, Rainwater and Kravitz, 2012).
From 1975 to 1990, breast cancer mortality in women slowly increased by 0.4% per year.
However, breast cancer mortality has decreased by 2.2% per year from 1990 to 2007
(Altekruse, Kosary, Krapcho et al., 2010). The percentage decline was larger among
younger women. From 1990 to 2007, mortality rates decreased by 3.2% per year among
women younger than 50, and by 2.0% per year among women 50 and older (Altekruse,
Kosary, Krapcho et al., 2010). The decline in breast cancer mortality has been attributed
to both improvements in breast cancer treatment and early detection (Berry, Cronin,
Plevritis et al., 2005). More specifically, from 1998 through 2007, breast cancer death
rates declined annually by 1.9% in Hispanics/ Latinas, 1.8% in non-Hispanic whites, 1.6%
in African Americans, 0.8% in Asian Americans/Pacific Islanders, and it has remained
unchanged among American Indian/Alaska Natives (Altekruse, Kosary, Krapcho et al.,
2010).
Breast cancer mortality rates have decreased annually in African American
women, but more slowly than in white women which has resulted in a growing disparity.
Between 2003 and 2007, African American women had a higher death rate than white
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women (Surveillance, Epidemiology and End Results (SEER) Program, 2010). The
factors that contribute to higher death rates among African American women include
differences in access, utilization of early detection and treatment, and differences in
tumor characteristics (Berry, Cronin, Plevritis, et al., 2005; Menashe, Anderson, Jatoi,
Rosenberg, 2009; Komenaka, Martinez, Pennington et al., 2010). This dissertation
addresses the utilization of early detection by examining the effect of provider reminders
on the offering mammography screening by physicians. An increase in the utilization of
early detection/screenings lowers the risk of death among African American women
because breast cancer is more treatable when it’s found early (Surveillance Epidemiology
and End Results, 2012).
It is estimated that 226,870 women will be diagnosed with breast cancer in 2012.
(Surveillance Epidemiology and End Results, 2012). Approximately 1 in 8.2 women will
receive a diagnosis of breast cancer during her lifetime (Cancer Facts and Figures, 2001).
From 2005-2009, the following percentages of women in the United States were
diagnosed with breast cancer: 0.0% under age 20; 1.8% between 20 and 34; 9.9%
between 35 and 44; 22.5% between 45 and 54; 24.8% between 55 and 64; 20.2% between
65 and 74; 15.1% between 75 and 84; and 5.7% of women 85 and older. The median age
at diagnosis for breast cancer from 2005 to 2009 was 61 years of age (Surveillance
Epidemiology and End Results, 2012).
In 2012, it is estimated that 39,510 women will die of breast cancer (Surveillance
Epidemiology and End Results, 2012). Between 2005 and 2009, the median age at death
for breast cancer was 68 years of age. The following percentages of women died of breast
cancer from 2005 to 2009: 0.0% under age 20; 0.9% between 20 and 34; 5.6% between
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35 and 44; 14.8% between 45 and 54; 21.4% between 55 and 64; 19.9% between 65 and
74; 22.0% between 75 and 84; and 15.5% of women 85 and older (Surveillance
Epidemiology and End Results, 2012).
To save one life from breast cancer, eighty-four women need to be screened
annually between 40 and 84 years. In addition, 5.3 women need to be screened annually
for breast cancer to gain one full year of life (Hendrick and Helvie, 2012). Breast cancer
alone accounts for 30% of all new cancer cases among women in the United States and it
accounts for 53% of cancer cases in all women (Siegel, Ward, Brawley, and Jemal, 2011).
2.2 BREAST CANCER SCREENING
Identification of the breast cancer at the earlier phases of progression improves
prognosis. Screening for breast cancer has been found to be beneficial because studies
have shown that screening by mammography reduces breast cancer by 25% and can
significantly reduce mortality from breast cancer (Islam and Aziz, 2012).
Research has shown that breast cancer screening reduces breast cancer death
among women 40 to 74 years of age (Humphrey, Helfand, Chan, and Woolf, 2002). In
women aged 40 to 49, breast cancer screening allows for early detection of high-risk
lesions, which may prompt advanced treatment and a lower subsequent breast cancer risk
(Kremer, Downs-Holmes, Novak, Lyons, Silverman, Pham, and Plecha, 2012). In
addition, biennial breast cancer screenings for women aged 50 to 69 years has resulted in
earlier breast cancer detection, and decreased breast cancer mortality (Grimshaw, Russell,
1993; Jemal et al., 2009).
The value in breast cancer screening for these age groups has helped physicians to
make diagnoses at earlier stages and as a result these patients have smaller tumors
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(Yasmeen, Romano, Tancredi, Saito, Rainwater and Kravitz, 2012). Research has shown
that the majority of physicians recommend annual breast cancer screening for women
aged 40 through 79 years, including women with short life expectancy (Yasmeen,
Romano, Tancredi, Saito, Rainwater and Kravitz, 2012).
Studies have shown that breast cancer incidence increases with age and more than
50% of cases occur in women without known major predictors (Cancer Facts and Figures,
2001). To this end, a study performed by Humphrey et al. (2002) revealed that women
older than 70 years of age have the highest incidence of breast cancer in the United States.
For this reason, Warner (2012) recommends that women between 40 and 74 receive a
breast cancer screening every 2 years to reduce risk of death from breast cancer. When
women are screened every two years, breast cancer risk is reduced by 15%. However,
based on findings from Warner (2012) there is about a 40% chance that patients will be
called back for further imaging tests and a 3% chance that patients will undergo biopsy,
with a benign breast cancer finding.
Many professional societies are uncertain of the appropriateness and costeffectiveness of breast cancer screenings in women younger than 50 and older than 74
years of age. This has caused many professional societies to issue conflicting
recommendations (Woolf, 2009). The USPSTF recommends against routine screening
mammography for women ages 40 to 49. However, they suggest biennial mammography
screenings from age 50 to 74 (Nelson et al., 2009). The American College of
Obstetricians and Gynecologists (ACOG) recommends mammography every one to two
years in women from 40 to 50 years of age and annually after age 50 with no specific age
for stopping. The American Cancer Society (ACS) differs slightly from both of these
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organizations. The ACS provides no specific age for discontinuing breast cancer
screening and believes that co-morbidity is the only qualifying factor for exclusion from
screening (Barbieri, 2010). The American Geriatrics Society recommends mammography
screening for older women unless they are unlikely to survive in the next 5 years or have
significant co-morbidities that would preclude breast cancer treatment (Raikand Fins,
2004). However, studies have shown that there is a small benefit in screening the elderly,
which may be outweighed by harms such as, anxiety, additional testing, and unnecessary
treatment (Rich and Black, 2000).
The prevalence of mammography screenings is a major concern for health care
providers because breast cancer is the second leading cause of cancer deaths among all
women in the United States (MMWR, 2010). Data from the 2008 Behavioral Risk Factor
Surveillance System were examined to determine the prevalence of mammography
screenings in the United States. The survey reported that there was a small reduction in
screenings among U.S. women aged 50-74 from 81.5% in 2006 to 81.1% in 2008. The
lowest prevalence of screenings were among those women aged 50-59 (79.9%), women
who did not finish high school (72.6%), American Indian/Alaska Natives (70.4%),
women with an annual income of less than $15,000 (69.4%), and women without health
insurance (56.3%). The highest prevalence of mammography screening was among
women in the Northeast region of the United States (MMWR, 2010). In fact,
mammography screening has been found more prevalent among African American
women than white and Hispanic women (Peek and Han, 2004; Bennett, Probst, and
Bellinger, 2011).
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On the contrary, studies have shown that white women are more likely than
African American or Hispanic women to be diagnosed earlier and have mammograms at
academic facilities, facilities with digital mammography services, and facilities that rely
exclusively on breast imaging specialists to conduct and read mammograms (Sassi et al,
2006). In comparison, research has shown that women with private insurance were more
likely than women without private insurance to have mammograms at facilities with these
same characteristics. Likewise, uninsured women and those with no usual source of care
have the lowest rates of reported mammogram use (Peek and Han, 2004).
Disparities in mammography screening are decreasing among medically
underserved populations but still persist among racial/ethnic minorities, rural populations,
and low-income women. According to a study done using the 2008 Behavioral Risk
Factor Surveillance System (BRFSS), there are cancer screening and treatment disparities
in rural minority populations. Research revealed that people who live in rural areas of the
United States are less likely to have breast cancer screenings than urban residents
(Bennett, Probst, and Bellinger, 2011).
In a study conducted on 2007 data from a mammography facility survey for the
metropolitan region of Chicago, Illinois, African American, Hispanic women and women
without private insurance were less likely to be diagnosed early for breast cancer when
compared to white women (Rauscher et al., 2012). However, they were more likely to
obtain mammography services from facilities that did not offer digital mammography,
but did offer film-screen mammography. The Digital Mammographic Imaging Screening
study conducted in 2005 has shown that film-screen and digital mammography are
equally accurate in screening for breast cancer (Pisano, Gatsonis, Hendrick, Yaffe, Baum,
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Acharyya, Conant, Fajardo, Bassett, D'Orsi, Jong, and Rebner, 2005).
2.3 BENEFITS OF ELECTRONIC MEDICAL RECORDS
EMR adoption is a major concern for health care organizations because of the
American Recovery and Reinvestment Act that was signed into law by President Barack
Obama in 2009. A primary objective of the statute is to modernize the nation’s
infrastructure by requiring all health care organizations to adopt EMRs by the year 2014
(American Recovery and Reinvestment Act, 2012; Fishman, 2011). EMR adoption has
increased from 105,000 physician practices to 130,000 physician practices since 2003
(Reardon and Davidson, 2007). This increase in EMR adoption represents only 20% of
the physician population in the United States. Moreover, the National Ambulatory
Medical Care Survey of 2005 revealed that only 17.6% of physicians reported using
EMRs in their practices (Burt and Sisk, 2005). This represented a 3% decrease in EMR
adoption from 2003 to 2005, as well as a major concern for health care organizations in
the United States.
Although EMR usage has declined in recent years, physicians who do use EMRs
have still made improvements in healthcare. Adams et al. (2003) found that EMR usage
in pediatric primary care offices resulted in children between 9 and 23 months 1.19 times
more likely to have a lead screening during their visit. In addition, Furukawa (2011)
found that EMR usage by U.S. office-based physicians was associated with 11.2% more
diagnostic/screening services provided per 20-minute period for chronic problems in
patients.
In 2009, Congress and President Obama also signed into law the Health
Information Technology for Economic and Clinical Health Act (HITECH), which
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authorized incentive payments through Medicare and Medicaid to providers and hospitals
when they use EMRs privately and securely to achieve specified improvements in care
delivery. HITECH promotes the “meaningful use” of EMRs, which is the usage of EMRs
by providers to achieve significant improvements in care, and then awards payments to
these providers for their improvements. Through this legislation, the federal government
will make available incentive payments totaling up to $27 billion over 10 years, or as
much as $44,000 through Medicare and $63,750 through Medicaid per provider. This
funding will provide important support for the creation of a nationwide system of EMRs
(Blumenthal and Tavenner, 2010).
Research has shown that primary care physician offices with EMRs provide more
accurate documentation of mammography screenings than paper based records (Clark et
al., 2009). However, evidence has shown that physician organizations are not using their
EMRs to their full potential. 39% of physician organizations in the United States are not
using their EMRs to send provider reminders to prompt providers to offer preventive care,
such as preventive care screenings (Schmittdiel et al., 2004).
Provider reminders can remind providers to offer services during routine visits
and remind patients to schedule care. A recent study found that 50% of health care
organizations use provider reminders to offer mammography screenings (Schmittdiel et
al., 2004). Patient visits to these types of organizations revealed that EMRs with provider
reminders were associated with 13.2% improvement in mammography screening rates
(Mandelblatt and Yabroff, 1999). Likewise, studies have found that the usage of provider
reminders resulted in an overall 13% improvement in preventive screenings (Balas et al.,
2000; Dexheimer et al., 2008). The results of these studies reveal that with the usage of
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EMR provider reminders, physicians are providing more preventive care to patients.
Provider reminders have improved clinical processes for a variety of conditions,
including ordering tests to determine hemoglobin and lipid levels, foot examinations,
counseling smokers, and diabetic eye examinations (Demakis, Beauchamp, Cull et al.,
2000). Fourteen of 19 studies on provider reminders used in preventive care showed
improvements in provider processes of care. These studies found that provider reminders
improve clinical processes for diabetes care, immunization, blood pressure screening, and
Pap smear tests, although the improvements often diminish if the reminders are stopped
(Mitchell and Sullivan, 2001).
Research has not been conducted to determine if the overall level of provider
reminder usage among physician offices improve the offering of mammography
screening (Schmittdiel et al., 2004). However, studies have shown that Americans
support the usage of provider reminders in physician offices. 78% of Americans favor the
use of provider reminders and believe that they could improve health care (Gaylin et al.,
2011). Additionally, more than 59% of Americans support health care information
sharing among providers and believe that provider reminders can reduce health care costs
(Gaylin et al, 2011).
In the outpatient setting, a challenge exists for providers and patients in follow-up
of abnormal mammography test results. Follow-up actions often have to be performed in
the future because of poor patient-provider communication for follow-up appointments
(Poon, Haas, Puopolo, Gandhi, Burdick, Bates, and Brennan, 2004). While good patientdoctor communication has long been recognized as a cornerstone for good-quality
medical care, provider reminders may be a form of communication to ensure that patients
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with abnormal test results receive the appropriate follow-up care (Billings and Stoeckle,
1999).
Systematic reviews have coincided in concluding that provider reminders have
been proven effective in improving follow-up care and increasing provider adherence to
preventive care standards and prescribing guidelines (Davis, Thomson, Oxman, &
Haynes, 1995; Hulscher, Wensing, Grol, van der Weijden, & van Weel, 1999; Wensing
& Grol, 1994). Grimshaw and Russell (1994) reported improvements in performance
according to standards in both hospital and general practice settings in several studies
where guidelines were imbedded in medical record cards and other forms. However,
Solomon, Hashimoto, Daltroy, and Liang (1998) cautioned that not all trials of provider
reminders have demonstrated effects. The effects of reminders often disappeared after the
reminders were stopped, suggesting that to be effective, reminders must be applied
continuously and incorporated into daily routines. Research has shown that asking health
providers to respond to reminders appears to boost effectiveness (Solomon, Hashimoto,
Daltroy, and Liang, 1998).
Axt-Adam, van der Wouden, and van der Does (1993), performed a review of
interventions that influenced physician test ordering. Findings from the review showed
that the effect of a provider reminder was enhanced when physicians noted a response as
to whether the reminder was followed. Both manual and computerized provider
reminders have been found to be similarly effective in inducing physicians in primary
care settings to perform various preventive services, such as immunization and
mammography screenings.
Computer-based provider reminders go beyond generic reminders about practice
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guidelines to integrate patient-specific information from a computer database to generate
patient-specific assessments or recommendations. A review of controlled trials of clinical
decision support systems found positive effects on physician performance for preventive
services and positive results with computer-based provider reminders (Hunt, Haynes,
Hanna, & Smith, 1998).
2.4 HOW PROVIDER REMINDERS WORK
Provider reminders are prompts given to a provider to cue them to perform a
desired action for a patient’s care at the time of the encounter (Riley, Galang, and Green,
2011). These prompts notify providers to offer services such as exams, tests, or medical
procedures during routine visits. Provider reminders may consist of a note in a patient’s
chart, a computer print-out, a message appearing on a computer screen, a verbal cue from
an assistant, a checklist, wall poster, flowchart, or other paper or computer-based job aids
that guide the health provider through the appropriate steps in a process.
The Task Force for Community Preventive Services reviewed studies focused on
influenza and pneumococcal polysaccharide vaccines. Based on the review, the Task
Force recommended the use of provider reminders in healthcare settings on the basis of
strong evidence of effectiveness in improving targeted vaccination coverage (Task Force
on Community Preventive Services, 2005). Although the review did not include an
evaluation of the effectiveness of provider reminders when implemented alone in
increasing targeted vaccination for Hepatitis B, the Task Force acknowledges that this
recommendation should be considered applicable to the Hepatitis B vaccine.
Overall, the Task Force recognized that their findings in the review were
applicable to providers and staff in most healthcare settings where improvements in
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coverage are needed (Task Force on Community Preventive Services, 2005). The major
assumption underlying provider reminders is that provider forgetfulness or lack of
awareness are major barriers to performance in accordance with standards, as opposed to
deficiency in knowledge or skill.
A Cochrane review from 2009 found that provider reminders generally achieve
small to modest improvements in provider behavior, with a trend toward larger
improvements for reminders that require a user to enter a response (Shojania, Jennings,
Mayhew, Ramsay, Eccles, and Grimshaw, 2009). In addition, provider reminders have
been shown to be an effective tool to increase immunization rates, adherence to
recommended diabetes and coronary artery disease care, and increase colorectal cancer
screening rates (Sequist, Gandhi, Karson, et al., 2005; Fiks, Grundmeier, Biggs, Localio,
and Alessandrini, 2007; Nease, Ruffin, Klinkman, Jimbo, Braun, Underwood, 2008;
Seres, Kirkpatrick, Tierney, 2009).
2.5 CONCEPTUAL FRAMEWORK
Studies have consistently found that individuals are more likely to have
preventive screenings when offered by providers (McPhee, Bird, Davis, Ha, Jenkins, and
Le, 1997). Grady et al. (1992) found that provider offering of mammography screening
had a stronger association with mammography participation compared with demographic
variables, health care utilization, attitudes, or health status. In contrast, patients with no
recent mammography screening reported the lack of a provider recommendation or offer
as a common barrier to getting a screening (Mamon, Shediac, Crosby, Sanders,
Matanoski, and Celentano, 1990; Kelly and Shank, 1992; Ruchlin, 1997; Brenes and
Pasket, 2000; Weitzman, Zapka, Estabrook, and Goins, 2001). Based on these studies, it
is important that provider reminders are in place to increase provider offering of
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preventive screenings for patients.
Physician offering of appropriate preventive screenings represents an intricate
part in the receipt of healthcare. Additionally, it provides important clues regarding the
success or failure of an intervention. Studies have acknowledged that physician offering
of preventive screenings, tests, or medications are legitimate outcome measures in the
implementation of an intervention to improve preventive health (Bastani, Yabroff, Myers,
Glenn, 2004).
The Behavioral Model of Health Services Use (Figure 2.1) explains that
understanding health services use is best achieved by focusing on social and individual
determinants (Andersen, 2008). Although the model has evolved over time, revisions
resulted mainly in additions to the model and did not change the fundamental base of the
model (Andersen, 2008). The first model suggested people’s use of health services is a
function of their predisposition to use services, factors which enable or impede use and
need for care (Andersen, 2008).
For the purposes of this study, predisposing variables were patient and physician
demographic/location characteristics. Patient demographic characteristics include race
and ethnicity. Physician demographic/location characteristics include physician type,
employment status of physician, owner of the practice, and practice type, region, and
metropolitan statistical area. Other variables in the model included, enabling as patient
family characteristics and EMRs and provider reminders. Patient family characteristics
include income and payment type. Perceived needs refer to patients’ reason for visit.
Patients’ reason for visit includes general medical exams and other medical exam. Lastly,
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more mammography screening ordered or provided by physicians represents perceived
needs and the process of medical care in the model.
Figure 2.1. Andersen’s Health Services Use Model: Variables influencing
mammography screening ordered or provided by physicians

Patient
Patients’ Reason
Demographic Patient Family
For Visit (e.g. Physician Demographic/
Characteristics Characteristics general medical Location Characteristics
(e.g. physician type,
(e.g. income,
(e.g. race,
exam, other
owner-solo, region,
ethnicity)
payment type) medical exam)
rurality)

EMRs and
Provider
Reminders

More
Mammography
Screening

Dexter et al. (2001) supports the principles in figure 1. In this study, research was
conducted over an 18-month period to examine the impact of provider reminders on
preventive screenings. Provider reminders were sent to healthcare providers to identify
eligible patients for preventive screenings that had not been ordered by the admitting
physician. For eligible patients, provider reminders resulted in higher ordering rates for
pneumococcal vaccination, prophylactic heparin, and prophylactic aspirin at discharge.
Figure 2.1 also shows that EMRs and provider reminders enable the need for
diagnostic screenings, such as mammography in patients. Specifically, EMRs assist in
keeping an accurate record of a patient’s diagnostic/screening records and provider
reminders notify physicians when patients are required to have a screening. Research
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conducted by Yabroff et al. (2010) strengthens and reinforces these principles illustrated
in the conceptual framework. Yabroff et al. (2010) found that healthcare providers in
practices with a full EMR system or in transition of installing/replacing an EMR system
were more likely than physicians in practices with paper charts to make more guidelineconsistent recommendations for diagnostic screenings (Yabroff, Klabunde, Yuan,
McNeel, Brown, Casciotti, Buckman, Taplin, 2010).
2.6 KNOWLEDGE GAP
As mentioned previously, there have not been any studies that examine provider
EMR usage, and the impact of provider reminders on offerings of mammography
screenings to patients. To fill this knowledge gap, this study contributes to the literature
by using recent, nationally representative, and racially diverse data from the 2008, 2009,
and 2010 National Ambulatory Medical Care Surveys. This study examines the following
(2) main hypotheses:
1. Mammography screenings will more likely be ordered or provided by physicians
who use EMR systems with reminders compared to physicians who do not use
EMR systems.
2. Mammography screenings will more likely be ordered or provided by physicians
who use EMR systems with reminders turned off or no reminders, compared to
physicians who do not use EMR systems.
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CHAPTER 3
METHODOLOGY

3.1 STUDY DESIGN
The National Ambulatory Medical Care Surveys (NAMCS) is a national survey
that collects information from non-federally employed office-based physicians about the
provision and use of ambulatory medical care services in the United States (CDC, 2012).
The CDC established NAMCS in 1973, and has conducted the survey from 1973-1981, in
1985, and annually since 1989. Participating physicians, with the exception of
anesthesiologists, pathologists, and radiologists who are excluded from the survey,
complete a one-page questionnaire for each patient visit sampled during a one-week
reporting period. Data is used to statistically describe the patients that utilize physician
services, and to make physician estimates as well as visit estimates based on the
conditions most often treated and the diagnostic and therapeutic services rendered.
Moreover, public health policy makers, health services researchers, and epidemiologists
use the data to describe and understand the changes that occur in medical care
requirements and practices.
In this study, the 2008, 2009, and 2010 National Ambulatory Medical Care
Surveys were merged or combined by a common identifier. 2,785 physicians are
represented in the study sample after excluding anesthesiologists, pathologists,
radiologists, and surgical care specialists. In addition, 8,348 women age 45 and older
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represent the patient study sample.
3.2 DATA ANALYSIS
The chi-square test is commonly used in quantitative analyses to examine
independence and goodness of fit (Chegg, 2012). In many national studies the chi-square
test has been used to assess EMR usage for quality improvement in health care, perceived
barriers to EMR adoption, and family practice residents’ perceptions regarding EMRs
(Aaronson, Murphy-Cullen, Chop, Frey, 2001; Burt, Sisk, 2005; DesRoches, Campbell,
Rao, Donelan, Ferris, Jha, Kaushal, Levy, Rosenbaum, Shields, Blumenthal, 2008).
In this study, chi-square testing was used to analyze physician ordering or
providing of mammography screenings by physician EMR usage and EMR reminder
usage. P-values less than 0.05 from the chi-square analyses determined the significance
of the variables of interest.
Logistic regression was used to estimate adjusted odds ratios and 95% confidence
intervals. For purposes of this study, the likelihood of mammography screening was
modeled in the logistic regression models for all hypotheses. The information from the
resulting analyses was used to summarize the associations between each variable of
interest.
ICD-9 coding was used to define two covariates used in the analyses, General
Medical Exam (IDC-9: 3100.0) and Other Medical Exam (ICD-9: 3240.0). All analyses
for this study incorporated sampling weights and were carried out using SAS version 9.3
(SAS, 2012).
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3.3 DEPENDENT VARIABLES
Based on the literature review, a dependent variable from the 2008-2010 NAMCS
was critical to the study. Question 7 from the NAMCS Patient Record Form was used as
a dependent variable in the analyses. Question 7 asks, “Mark (X) all ordered or provided
at this visit; (4). “Mammography” is among the alternatives. A missing category was also
created to account for the “No answer” responses in this question.
3.4 INDEPENDENT VARIABLES
Based on the literature review, several independent variables from the 2008-2010
NAMCS were key in this study. These variables include Question 17 (2008-2009) and
18g from the Electronic Medical Record Supplement of the 2008-2010 NAMCS.
Question 17 (2008-2009) asks, “Does the reporting location use an electronic medical
record (EMR) or electronic health record (EHR) system? – (1) Yes, all electronic; (2) Yes,
part paper and part electronic; (3) No; (-8) Don’t know; or (-9) Blank?” The response
categories ‘(1) Yes, all electronic and (2) Yes, part paper and part electronic’ were
combined into one category labeled “Yes” due to a low response rate in the response
categories (1) and (2) separately. A missing category was also created to account for the
“Don’t know”, and “Blank” responses in this question.
Question 18g asks, “Does the reporting location have a computerized system for
reminders for guideline-based interventions or screening tests – (1) Yes; (2) No; or (3)
Unknown?” A missing category was created to account for the “Unknown” responses in
this question. Both question 17 (2008-2009) and 18g from the Electronic Medical Record
Supplement of the 2008-2010 NAMCS were combined to form the variable Physician
EMR Use. Physician EMR Use was classified into three groups: No EMR, EMR no
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reminder, and EMR with reminder. Due to low response rates, the group EMR no
reminder includes EMR with turned off reminders and EMR with no reminders.
3.5

COVARIATES
3.5.1 PHYSICIAN COVARIATES
Based on the literature review, several covariates from the 2008-2010 NAMCS

were key in describing the characteristics of the physicians’ and their practices. The
covariates that describe the location of the physician practices include region and
metropolitan statistical area. Region was classified into four groups: Northeast, Midwest,
South and West. Metropolitan statistical area was classified into two groups:
Metropolitan area and Non-Metropolitan area.
The covariates that describe physician and practice type include employment
status of the physician and owner-solo. Employment status of the physician was
classified into three groups: owner, employee, and contractor. Due to low response rates
in the categories of physician practice type and owner of practice, both categories were
combined to form the Owner-solo category. The Owner-solo category was classified into
three groups: Physician, Health Maintenance Organization/other practices, and
Community Health Centers. The response groups Community Health Centers and
Academic Health Centers both had low response rates, and therefore were combined into
one group labeled Community Health Centers. The response group Health Maintenance
Organization/ other practices was created to include responses to Health Maintenance
Organization, Other hospital, Other health care corporation, and Other, due to low
response rates in all of these groups.
The covariates that describe physician appointments include same day
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appointments, and the time it takes to get an appointment for a routine medical exam.
Same day appointments were classified into two groups: Yes and No. Lastly, the time it
takes to get an appointment for a routine medical exam was classified into two groups:
Within 1 week and 1week - 1 or more months. The response group 1 week – 1 or more
months was created to include responses to 1-2 weeks, 3-4 weeks, 1-2 months, and 3 or
more months due to low response rates in each of these groups.
The covariate that describes the year that the survey was conducted is survey year.
Survey year was classified into three groups: 2008, 2009, and 2010.
3.5.2 PATIENT COVARIATES
Based on the literature review, several covariates from the 2008-2010 NAMCS
were crucial in describing the characteristics of patients. These variables include race,
ethnicity, Rurality, payment type, income quartile of the ZIP Code or Census tract where
patient lives (income), patients’ reason for visit, and survey year. Race was classified into
three groups: White, Black, and Other. The response group “Other” was created to
include responses to “Asian”, “Pacific Islander”, “American Indian”, and “Multiracial”,
due to low response rates in each of these categories. Ethnicity was classified into two
groups: Hispanic and Non-Hispanic. Rurality was classified into two groups: urban and
rural.
Payment type was classified into three groups: Private insurance, Medicare or
Medicaid/SCHIP, and Self-pay or other form of payment. The response category
“Medicare or Medicaid/SCHIP” was created to include responses to “Medicare” and
“Medicaid/SCHIP”, due to low response rates in each of these categories. The response
group “Self-pay or other form of payment” was created to include responses to
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“Worker’s Compensation”, “Self-pay”, “Other”, and “No charge/charity”, due to low
response rates in each of these groups.
The income quartile of the ZIP Code or Census tract where patient lives (income)
was classified into four groups: $32,793 or less, $32,794-$40,626, $40,627-$52,387, and
$52,388 or more. Patient’s reason for visit was classified into two groups: general
medical exam (ICD-9: 3100.0) and Other Medical Exam (ICD-9: 3240.0). Lastly, survey
year was classified into three groups: 2008, 2009, and 2010.
3.6 CONTROL VARIABLES
3.6.1 PHYSICIAN COVARIATES
Based on the literature review, one control variable from the 2008-2010 NAMCS
was critical to describing physician characteristics in the study. Physician specialty was
selected as a control variable in this study, and it was restricted to general/family practice,
internal medicine, obstetrics/gynecology, and dermatology/oncology. Due to low
response rates in dermatology and oncology, both groups were combined to form
dermatology/oncology.
3.6.2 PATIENT COVARIATES
Based on the literature review, several control variables from the 2008-2010
NAMCS were crucial in describing patient characteristics in the study. These variables
include age and sex. Sex was restricted to female, and age was restricted to 45 and over.
3.7 LIMITATIONS
A limitation in this study is that physicians from the Indian Health Service are not
included in the NAMCS survey. In addition, there was a high percentage of item nonresponse in questions used in the analyses. As a result, biased estimates and
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underestimated standard errors are calculated, particularly since the NAMCS uses a
single imputation algorithm.
A second limitation for this study was the fact that question 7 from the 2008-2010
NAMCS Patient Record Form, should be reworded into two separate questions. The first
question should ask: “Were any diagnostic/screening services ordered at this visit?” and
the second question should ask: “Were any diagnostic/screening services provided at this
visit?” By separating the question, more specific analyses can be performed on the data.
Researchers will have the ability to determine the amount of diagnostic/screening
services ordered and the amount provided to each patient.
A third limitation for this study is that it cannot be determined from the checkmark response choices listed for question 7, whether mammography services ordered or
provided are routine or abnormal follow-up. Also, it cannot be determined from NAMCS
the type of EMR systems physicians are using. Providing these distinctions will allow for
more exact or specific analyses as it relates to mammography services and physician
EMR use.
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CHAPTER 4
RESULTS
4.1 DESCRIPTION OF THE PHYSICIAN POPULATION
The organizational and geographical characteristics of physicians who could order
or provide mammography screenings are presented in Table 4.1. More than half of the
physicians are in the general/family practice specialty (55.3%). Many are owners (56.1%)
who own health care clinics (73.9%) and provide appointments to their patients within 1
week (47.0%) and between 1 week and 1 or more months (53.0%). Likewise, more than
half of physicians provide same day appointments (57.8%) to their patients. The
physicians are evenly distributed throughout the four regions of the United States, mainly
in metropolitan areas (90.1).
4.2 PHYSICIAN EMR AND PROVIDER REMINDER USE
The use of EMR and provider reminders by physicians is presented in Table 4.2.
Significant findings in this table indicate that no EMR was more common among
physicians located in the Northeast (56.9%), Midwest (55.4%), Western (53.2%) and
Southern (51.9%) regions of the United States. No EMR was also more common among
community health centers (61.9%), HMO/other practices (77.4%), and physicians (47.7%)
who own health clinics, and by physicians who are contractors (67.6%), employees
(53.9%), and owners (53.0%) of health care organizations. In addition, significant
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findings indicate that no EMR was more common among 50.3% of physicians who
provide same day appointments, and 59.1% of physicians who do not provide same day
appointments to their patients. The following physician characteristics were not
significant: specialty, metropolitan statistical area, the time it takes to get an appointment,
and survey year.
4.3 PHYSICIAN ORDERING OR PROVIDING OF MAMMOGRAPHY
Table 4.3 presents physicians who ordered or provided a mammography
screening for a patient during a visit. Significant findings in this table indicate that
ordering or providing mammography screenings was more common among physicians in
the obstetrics/gynecology (9.3%) specialty, than in internal medicine (2.8%),
general/family practice (1.8%), and dermatology/oncology (1.3%). Moreover, the
likelihood of physicians not ordering or providing mammography screenings to their
patients was more common in the dermatology/oncology (98.7%), general/family
practice (98.2%), and internal medicine (97.2%) specialty, than in obstetrics/gynecology
(90.7%).
4.4 THE CHARACTERISTICS OF WOMEN WHO VISITED A PHYSICIAN
Table 4.4 describes the characteristics of women aged 45 and older who visited a
physician in one of the specialties included in this study, and it also indicates the EMR
use of the physician visited. The women are mostly white (70.0%) and Non-Hispanic
(89.2%) who live in urban (83.8%) areas of the United States. Many of these women
have private insurance (44.7%) or Medicare/Medicaid/SCHIP (44.5%) and make visits to
physicians for general medical exams (54.3%).
Visits to physicians who have EMR and use reminders were more common
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among white (36.8%), black (35.8%), other (31.9%), Non-Hispanic (39.7%), and
Hispanic (37.4%) women, than visits to physicians who have EMR and do not utilize
reminders. In addition, visits to physicians who have EMR and use reminders were more
common among women in the income quartile $32,794-$40,626 (43.6%). There were
several patient characteristics that were not significant in this table, which include reason
for visit, and survey year.
4.5 RELATIONSHIP BETWEEN PHYSICIAN CHARACTERISTICS AND
LIKELIHOOD THAT A MAMMOGRAM WOULD BE ORDERED/PROVIDED
Table 4.5 presents the proportion of women for whom a mammogram was
ordered or provided. Physician EMR use was not associated with ordering or providing a
mammogram. A mammogram being ordered or provided by a physician was more
common among women who have private insurance (12.4%) in the income quartile
$52,388 or more (12.3%) and who live in urban (9.7%) areas of the United States. There
were several physician and patient characteristics that were not significant in this table,
which include physician EMR use, race, ethnicity, reason for visit, and survey year.
4.6 PERSONAL FACTORS ASSOCIATED WITH THE LIKELIHOOD THAT A
WOMAN WOULD HAVE A MAMMOGRAPHY ORDERED/PROVIDED,
ADJUSTED ANALYSIS
In table 4.6, three logistic regression analyses were conducted to understand the
adjusted odds of a woman receiving a mammography. The first analysis adjusts for the
personal characteristics of women, the second analysis adds physician EMR use, and the
final analysis adjusts for all physician and patient characteristics. There were only two
factors that were significant: payment type and survey year. Significant findings in the
table indicate that women on Medicare/Medicaid/SCHIP (OR = 0.676, 95% CI 0.3740.944) and who self-pay for health care (OR = 0.540, 95% CI 0.434-0.975) had
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significantly lower odds of receiving a mammography, than women who had private
insurance. In addition, women in survey year 2008 (OR=0.687, 95% CI 0.556-0.848) had
significantly lower odds of receiving a mammography, than women in 2010.
Table 4.7 presents the odds of a woman receiving a mammography screening,
based on physician EMR use and patient characteristics. Significant findings in table 7
were found in the income quartile of the zip code or census tract, survey year, and
payment type for the sample of women. These findings indicate that women in 2008 (OR
= 0.695, 95% CI 0.555-0.870) and in the income quartile $52,388 or more (OR = 0.782,
95% CI 0.616-0.993) who are on Medicare/Medicaid/SCHIP (OR=0.709, 95% CI 0.3850.910) or self-pay for health care (OR = 0.845, 95% CI 0.325-0.956) have significantly
lower odds of receiving mammography screenings compared to women in the income
quartile $40,627-$52,387 with private insurance in 2010.
In table 4.7, physician EMR use was not significantly associated with the adjusted
odds that a mammogram would be ordered/provided. This finding is inconsistent with the
hypothesis that mammography screenings will more likely be ordered or provided by
physicians who have EMR and use reminders and by physicians that have EMR but do
not utilize reminders, compared to physicians who do not use EMR systems.
Table 4.8 presents the odds of a woman receiving a mammography based on
physician EMR use, patient characteristics, and physician practice characteristics.
Significant findings indicate that women who visit obstetrics/gynecology (OR = 0.190,
95% CI 0.142-0.254) and internal medicine practices (OR = 0.553, 95% CI 0.393-0.778)
have significantly lower odds of receiving a mammography, compared to women visiting
general/family practices. Women on Medicare/Medicaid/SCHIP (OR=0.633, 95% CI
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0.271-0.919) have significantly lower odds of receiving mammography screenings
compared to women who have private insurance. In addition, women have significantly
lower odds of receiving mammography screenings at physician offices that provide same
day appointments (OR= 0.777, 95% CI 0.605-0.999) and appointments between 1 week –
1 or months (OR = 0.753, 95% CI 0.581-0.976), compared to physician offices that do
not provide same day appointments and appointments within 1 week.
In table 4.8, physician EMR use was not significantly associated with the
odds that a woman would have a mammogram provided/ordered. These findings are
inconsistent with the hypothesis that mammography screenings will more likely be
ordered or provided by physicians who use EMR systems with reminders turned off
/no reminders, compared to physicians who do not use EMR systems.
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Table 4.1. Physicians who could Order or Provide Mammography Screenings by
Organizational and Geographical Characteristics, 2008-2010 National Ambulatory
Medical Care Surveys
(Unweighted Estimates = 2,785)
S.E.
(%)

Variables
Specialty
General/Family Practice
Internal Medicine
Obstetrics/gynecology
Dermatology / oncology

(%)

(n)

55.3
20.9
17.9
5.9

1,539
583
498
165

1.9
2.1
1.3
0.4

Region
Northeast
Midwest
South
West

20.0
23.7
31.1
25.2

555
661
866
703

1.6
1.1
1.4
1.1

Metropolitan Statistical Area
Metropolitan Area
Non-Metropolitan Area

90.1
9.9

2,508
277

1.1
1.1

Employment Status of
Physician1
Owner
Employee
Contractor

56.1
39.1
4.8

1,563
1,089
133

1.9
1.9
0.6

Owner-Solo2
Physician
HMO / Other Practices
Community Health Center

73.9
16.9
9.2

2,057
473
255

1.6
1.5
0.6

Time It Takes To Get
Appointment
Within 1 week
1 week – 1 or more months

47.0
53.0

1,308
1,477

1.6
1.6

Same Day Appointments
Yes
No

57.8
42.2

1,609
1,176

1.3
1.3

Survey Year
2008
31.7
884
1.8
2009
33.8
941
1.6
2010
34.5
960
1.6
1
Employment Status of Physician refers to a physician who is employed as an owner; or an
employee or contractor in a healthcare organization.
2
Owner-Solo refers to the physician or healthcare organization that owns a clinic.
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Table 4.2. Distribution of physician’s EMR Reminder use by physician characteristics
(MD level), 2008-2010 National Ambulatory Medical Care Surveys
Have EMR (n=1,279)
Use reminders

No EMR
(n=1,506)

Pvalue

Variables
Specialty
General/Family Practice
Internal Medicine
Obstetrics/gynecology
Dermatology/oncology

% (n)

Do not use
reminders/
Turned off
reminders
% (n)

36.4 (560)
25.2 (147)
25.1 (125)
24.2 (40)

15.7 (242)
13.7 (80)
10.2 (51)
20.6 (34)

47.9 (737)
61.1 (356)
64.7 (322)
55.2 (91)

Region**
Northeast
Midwest
South
West

30.5 (169)
29.8 (197)
34.1 (295)
28.9 (203)

12.6 (70)
14.8 (98)
14.0 (121)
17.9 (126)

56.9 (316)
55.4 (366)
51.9 (450)
53.2 (374)

Metropolitan Statistical Area
Metropolitan Area
Non-Metropolitan Area

32.4 (813)
14.4 (40)

15.5 (388)
13.7 (38)

52.1 (1,307)
71.8 (199)

Employment Status of Physician1**
Owner
Employee
Contractor

36.4 (569)
28.2 (307)
24.1 (32)

10.6 (165)
17.9 (195)
8.3 (11)

53.0 (829)
53.9 (587)
67.6 (90)

Owner-Solo2**
Physician
HMO / Other Practices
Community Health Center

33.2 (683)
14.6 (69)
17.3 (44)

19.1 (392)
8.0 (38)
20.8 (53)

47.7 (982)
77.4 (366)
61.9 (158)

Time It Takes To Get Appointment
Within 1 week
1 week – 1 or more months

31.8 (416)
22.7 (336)

20.9 (273)
17.2 (254)

47.3 (619)
60.1 (887)

Same Day Appointments**
Yes
No

25.1 (403)
25.3 (297)

24.6 (396)
15.6 (183)

50.3 (810)
59.1 (696)

< .00

Survey Year
2008
30.1 (266)
9.2 (81)
60.7 (537)
2009
31.9 (300)
17.7 (167)
50.4 (474)
2010
27.3 (262)
21.1 (203)
51.6 (495)
1
Employment Status of Physician refers to a physician who is employed as an owner; or an
employee or contractor in a healthcare organization.
2
Owner-Solo refers to the physician or healthcare organization that owns a clinic.
** = Chi-Square Analysis significant p < .05

0.39

%

(n)
0.35

0.01

0.46

< 0.00

0.01

0.26
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Table 4.3. Physicians who Ordered or Provided a Mammography Screening for a patient
during a Visit, 2008-2010 National Ambulatory Medical Care Surveys
No
Mammography
(n = 1,434)
%
n

Variables
Specialty
General/Family Practice
98.2
612
Internal Medicine
97.2
279
Obstetrics/gynecology
90.7
233
Dermatology/oncology
98.7
310
** = Chi-Square Analysis significant p < .05

Mammography
ordered/provided
(n = 47)
%
n
S.E.

P-value

< 0.01
1.8
2.8
9.3
1.3
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11
8
24
4

0.1
0.2
0.1
0.3

Table 4.4. Women age 45 and older who visited a physician, by physician EMR
Reminder use, 2008-2010 National Ambulatory Medical Care Surveys
All women
(n = 8,348)

Variables
Race**
White
Black
Other

70.0 (5,844)
18.4 (1,536)
11.6 (968)

36.8 (2,153)
35.8 (550)
31.9 (309)

18.3 (1,068)
22.5 (346)
24.2 (234)

44.9 (2,623)
41.7 (640)
43.9 (425)

Ethnicity**
Hispanic
Non-Hispanic

10.8 (899)
89.2 (7,449)

37.4 (336)
39.7 (2,958)

16.3 (147)
16.4 (1,219)

46.3 (416)
43.9 (3,272)

Income**
$32,793 or less
$32,794 -$40,626
$40,627-$52,387
$52,388 or more

24.5 (2,042)
24.0 (2,005)
25.0 (2,085)
26.5 (2,216)

35.4
43.6
36.7
38.8

18.9
17.2
16.6
16.3

45.7
39.2
46.7
44.9

Rurality**
Urban
Rural
Payment Type**
Private Insurance
Medicare or
Medicaid/SCHIP
Self-pay/other
form of payment
Reason for Visit
General Medical
Exam
Other Medical
Exam

%

(n)

Physician EMR Use
Have EMR (n = 4,660)
No EMR
(n = 3,688)
Use
Do not use
reminders
reminders/
Turned off
reminders
%

(n)

%

(n)

Pvalue

% (n)
0.04

0.05

0.03
(723)
(875)
(766)
(859)

(385)
(344)
(347)
(361)

(934)
(786)
(972)
(996)
0.01

83.8 (6,995)
16.2 (1,353)

38.6 (2,702)
40.9 (554)

16.7 (1,169)
17.4 (235)

44.7 (3,124)
41.7 (564)

44.7 (3,730)
44.5 (3,717)

42.4 (1,581)
37.1 (1,379)

14.3 (535)
18.9 (702)

43.3 (1,614)
44.0 (1,636)

10.8 (901)

33.6

17.8 (160)

48.6 (438)

< 0.01

(303)

0.12
54.3 (4,533)

39.1 (1,773)

18.4 (832)

42.5 (1,928)

45.7 (3,815)

33.5 (1,279)

20.3 (776)

46.2 (1,760)

Survey Year
2008
24.4 (2,039) 29.6 (603)
2009
33.0 (2,751) 43.6 (1,199)
2010
42.6 (3,558) 41.9 (1,492)
** = Chi-Square Analysis significant p < .05
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0.08
18.1
12.4
18.4

(370)
(342)
(654)

52.3 (1,066)
44.0 (1,210)
39.7 (1,412)

Table 4.5. Proportion of women for whom a mammogram is ordered or provided, by
physician characteristics, 2008-2010 National Ambulatory Medical Care Surveys
No
mammography
(n = 7,562)
%
(n)

Mammography
ordered/provided
(n = 786)
%
(n)

P-value

Variables
Physician EMR Use
No EMR
EMR, no reminder
EMR, with reminder

90.8
91.1
90.1

(3,349)
(1,244)
(2,969)

9.2
8.9
9.9

(339)
(122)
(325)

Race
White
Black
Other

90.4
90.9
91.4

(5,284)
(1,397)
(885)

9.6
9.1
8.6

(560)
(139)
(83)

Ethnicity
Hispanic
Non-Hispanic

89.4
90.6

(804)
(6,752)

10.6
9.4

(95)
(697)

0.23

Income**
$32,793 or less
$32,794 – $40,626
$40,627-$52,387
$52,388 or more

92.4
90.8
91.6
87.7

(1,887)
(1,821)
(1,910)
(1,944)

7.6
9.2
8.4
12.3

(155)
(184)
(175)
(272)

0.01

Rurality**
Urban
Rural

90.3
92.5

(6,319)
(1,252)

9.7
7.5

(676)
(101)

Payment Type**
Private Insurance
Medicare or Medicaid/SCHIP
Self-pay/other form of payment

87.6
93.4
91.5

(3,267)
(3,472)
(824)

12.4
6.6
8.5

(463)
(245)
(77)

Reason for Visit
General Medical Exam
Other Medical Exam

92.3
91.7

(4,185)
(3,498)

7.7
8.3

(348)
(317)

(1,847)
(2,502)
(3,213)

9.4
9.1
9.7

(192)
(249)
(345)

0.66

0.75

0.01

< 0.01

Survey Year
2008
90.6
2009
90.9
2010
90.3
** = Chi-Square Analysis significant p < .05

0.32

0.18
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Table 4.6. Odds that a woman will receive a mammogram, adjusting for patient
characteristics, 2008-2010 National Ambulatory Medical Care Surveys

Variables
Race
White
Black
Other

(n = 8,348)
Adjusted Odds Ratio
OR
95% CI

S.E.

1.000
0.984
1.389

ref
(0.749-1.291)
(0.891-2.165)

0.0
0.3
0.2

Ethnicity
Hispanic
Non-Hispanic

1.271
1.000

(0.950-1.784)
ref

0.2
0.0

Income
$32,793 or less
$32,794 – $40,626
$40,627-$52,387
$52,388 or more

1.054
0.901
1.000
0.834

(0.801-1.387)
(0.703-1.154)
ref
(0.664-1.047)

0.1
0.1
0.0
0.2

Rurality
Urban
Rural

0.810
1.000

(0.623-1.053)
ref

0.1
0.0

1.000
0.676

ref
(0.374-0.944)

0.0
0.1

0.540

(0.434-0.975)

0.2

0.851
1.000

(0.639-1.096)
ref

0.2
0.0

Payment Type
Private Insurance
Medicare or
Medicaid/SCHIP**
Self-pay/other form of
payment**
Reason for Visit
General Medical Exam
Other Medical Exam

Survey Year
2008**
0.687
(0.556-0.848)
2009
0.979
(0.803-1.194)
2010
1.000
ref
** = Logistic Regression Analysis significant, 95% CI does not include 1
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0.1
0.1
0.0

Table 4.7. Odds that a woman will receive a mammogram, adjusting for physician EMR
use and patient characteristics, 2008-2010 National Ambulatory Medical Care Surveys
(n = 8,348)
Adjusted Odds Ratio
OR

95% CI

S.E.

1.000
0.858
0.839

ref
(0.663-1.112)
(0.690-1.019)

0.0
0.1
0.1

Race
White
Black
Other

1.000
0.894
1.443

ref
(0.677-1.182)
(0.905-2.302)

0.0
0.1
0.2

Ethnicity
Hispanic
Non-Hispanic

1.344
1.000

(0.922-1.959)
ref

0.2
0.0

Income
$32,793 or less
$32,794 – $40,626
$40,627-$52,387
$52,388 or more**

1.029
0.969
1.000
0.782

(0.771-1.374)
(0.743-1.265)
ref
(0.616-0.993)

0.1
0.1
0.0
0.1

Rurality
Urban
Rural

0.875
1.000

(0.662-1.156)
ref

0.1
0.0

Payment Type
Private Insurance
Medicare or Medicaid/SCHIP**
Self-pay/other form of payment**

1.000
0.709
0.845

ref
(0.385-0.910)
(0.325-0.956)

0.0
0.1
0.2

Reason for Visit
General Medical Exam
Other Medical Exam

0.918
1.000

(0.787-1.076)
ref

0.1
0.0

Survey Year
2008**
0.695
(0.555-0.870)
2009
1.013
(0.823-1.247)
2010
1.000
ref
** = Logistic Regression Analysis significant, 95% CI does not include 1

0.1
0.1
0.0

Variables
Physician EMR Use
No EMR
EMR, no reminder
EMR, with reminder
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Table 4.8. Odds that a woman will receive a mammogram, adjusting for physician EMR
use, patient characteristics, and physician practice characteristics, 2008-2010 National
Ambulatory Medical Care Surveys

Variables
Physician EMR Use
No EMR
EMR, no reminder
EMR, with reminder

(n = 8,348)
Adjusted Odds Ratio
OR

95% CI

S.E.

1.000
0.777
1.058

ref
(0.553-1.092)
(0.816-1.372)

0.0
0.2
0.1

Physician Practice Characteristics
Specialty
General/Family Practice
Internal Medicine**
Obstetrics/gynecology**
Dermatology/oncology

1.000
0.553
0.190
0.889

ref
(0.393-0.778)
(0.142-0.254)
(0.474-1.668)

0.0
0.2
0.1
0.3

Region
Northeast
Midwest
South
West

1.000
1.368
0.945
0.908

ref
(0.924-2.026)
(0.671-1.332)
(0.633-1.305)

0.0
0.2
0.2
0.2

Metropolitan Statistical Area
Metropolitan Area
Non-Metropolitan Area

0.564
1.000

(0.335-0.952)
ref

0.3
0.0

Employment Status of Physician1
Owner
Employee
Contractor

1.000
0.889
0.868

ref
(0.646-1.224)
(0.357-2.111)

0.0
0.1
0.4

Owner-Solo2
Physician
HMO / Other Practices
Community Health Center

1.000
1.109
1.234

ref
(0.733-1.676)
(0.581-2.618)

0.0
0.2
0.3

Time It Takes To Get
Appointment
Within 1 week
1 week – 1 or more months**

1.000
0.753

ref
(0.581-0.976)

0.0
0.1

Same Day Appointments
Yes**

0.777

(0.605-0.999)

0.1
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No

1.000

ref

0.0

Patient Characteristics
Race
White
Black
Other

1.000
0.827
1.723

ref
(0.563-1.216)
(0.976-3.039)

0.0
0.2
0.3

Ethnicity
Hispanic
Non-Hispanic

1.063
1.000

(0.636-1.778)
ref

0.2
0.0

Income
$32,793 or less
$32,794 – $40,626
$40,627-$52,387
$52,388 or more

0.969
0.957
1.000
0.750

(0.648-1.450)
(0.681-1.345)
ref
(0.553-1.018)

0.1
0.2
0.0
0.3

Rurality
Urban
Rural

1.002
1.000

(0.630-1.594)
ref

0.2
0.0

Payment Type
Private Insurance
Medicare or Medicaid/SCHIP**
Self-pay/other form of payment

1.000
0.633
0.747

ref
(0.271-0.919)
(0.661-1.989)

0.0
0.1
0.2

Reason for Visit
General Medical Exam
Other Medical Exam

0.989
1.000

(0.893-1.125)
ref

0.1
0.0

Survey Year
2008
2009
2010

1.087
1.039
1.000

(0.664-1.780)
(0.816-1.323)
ref

0.2
0.1
0.0

1

Employment Status of Physician refers to a physician who is employed as an owner; or an
employee or contractor in a healthcare organization.
2
Owner-Solo refers to the physician or healthcare organization that owns a clinic.
** = Logistic Regression Analysis significant, 95% CI does not include 1
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CHAPTER 5
DISCUSSION
5.1 CONCLUSIONS
This study examines the relationship between EMRs and provider reminders and
the likelihood that mammography screenings will be ordered or provided by physicians.
Overall, there were not any significant findings regarding woman having a
mammography ordered or provided by a physician that has an EMR system with
reminders, EMR system with no reminders, and no EMR system. More than half of
physicians who could order or provide mammography screenings were general/family
practice physicians who were owners of solo clinics. These physicians are evenly
distributed throughout the four regions of the United States, mainly in metropolitan areas.
Most physicians who actually ordered or provided a mammography were in the
obstetrics/gynecology specialty. However, the odds of a woman having a mammography
ordered or provided by an obstetrician/gynecologist were significantly lower compared to
a general/family physician. Based on these findings, women past childbearing age have
more general/family physicians providing them with routine care.
Research from the 2000 and 2005 National Health Interview Survey found that
women ages 50 to 64 were more likely to report a recent screening mammogram if they
reported talking to a physician within the past 12 months and were covered by private
insurance (Breen et al., 2011). Similarly, our research concluded that women on
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Medicare/Medicaid/SCHIP and those who self-pay for healthcare were less likely to have
a mammography ordered or provided compared to women who have private insurance.
We speculate that general/family physicians experience difficulty referring self-pay and
Medicare/Medicaid/SCHIP patients for specialty care, such as mammography screenings.
This may be due to patients being reluctant to pay a co-pay for mammography screenings,
the short supply of specialists in the area, long waiting lists for specialists, specialists not
accepting or limiting the number of patients who are covered by
Medicare/Medicaid/SCHIP or self-pay, and low reimbursement rates. Our speculations
are supported by research conducted in 2007 by Hurley, Felland and Lauer which
acknowledges that community health centers in Seattle, Washington are facing serious
challenges referring both uninsured and Medicaid patients because there are fewer
specialists relative to the population (Hurley, Felland and Lauer, 2007).
The Affordable Care Act is set to expand preventive services under the Medicaid
program for the low-income and disabled. Beginning in 2014, Medicaid will be required
to cover recommended preventive services and immunizations. The federal government
will contribute an additional 1% of the cost of those services if they are provided by the
states with no cost sharing for patients. Overall, this will make the referral process less
difficult for physicians who refer self-pay and Medicare/Medicaid/SCHIP patients to
specialists because patients will no longer have a co-pay for mammography screenings.
Although our findings indicated there was no association between physician EMR
use and women receiving a mammogram, it is still important that physicians who have
EMRs with or without reminders “meaningfully use” EMRs to achieve improvements in
mammography screening. The Health Information Technology for Economic and Clinical
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Health Act (HITECH) of 2009 promotes the “meaningful use” of EMRs, which is the
usage of EMRs by providers to achieve significant improvements in care, and then
awards payments to these physicians for their improvements. This is important because
our findings indicate that physicians are ordering/providing mammography screenings for
women who self-pay and on Medicare and Medicaid at lower rate than women who have
private insurance. To address this problem, the HITECH statue authorizes incentive
payments through Medicare and Medicaid to physicians and hospitals that use EMRs
privately and securely to achieve specified improvements in care delivery. The federal
government awards incentive payments totaling up to $27 billion over 10 years, or as
much as $44,000 through Medicare and $63,750 through Medicaid per provider. This
funding will help encourage physicians in all specialties to improve the
ordering/providing of mammography screenings to women who are on
Medicare/Medicaid/SCHIP in all races, ethnicities, and socioeconomic backgrounds.
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